Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Phase 2 Study of EC145 Alone Versus EC145+Docetaxel Versus Docetaxel Alone in Participants With FR(++) 2nd Line Non Small Cell Lung Cancer
A Randomized, Open-label Phase 2 Study of EC145 Single-agent and the Combination of EC145 Plus Docetaxel Versus Docetaxel Alone in Participants With Folate-receptor Positive [FR(++)] Second Line NSCLC
Status: Enrolling
Updated:  2/8/2013
Gabrail Cancer Center
mi
from
Canton, OH
Phase 2 Study of EC145 Alone Versus EC145+Docetaxel Versus Docetaxel Alone in Participants With FR(++) 2nd Line Non Small Cell Lung Cancer
A Randomized, Open-label Phase 2 Study of EC145 Single-agent and the Combination of EC145 Plus Docetaxel Versus Docetaxel Alone in Participants With Folate-receptor Positive [FR(++)] Second Line NSCLC
Status: Enrolling
Updated: 2/8/2013
Gabrail Cancer Center
mi
from
Canton, OH
Click here to add this to my saved trials
Phase 2 Study of EC145 Alone Versus EC145+Docetaxel Versus Docetaxel Alone in Participants With FR(++) 2nd Line Non Small Cell Lung Cancer
A Randomized, Open-label Phase 2 Study of EC145 Single-agent and the Combination of EC145 Plus Docetaxel Versus Docetaxel Alone in Participants With Folate-receptor Positive [FR(++)] Second Line NSCLC
Status: Enrolling
Updated:  2/8/2013
Willamette Valley Cancer Institute/Research Ctr
mi
from
Eugene, OR
Phase 2 Study of EC145 Alone Versus EC145+Docetaxel Versus Docetaxel Alone in Participants With FR(++) 2nd Line Non Small Cell Lung Cancer
A Randomized, Open-label Phase 2 Study of EC145 Single-agent and the Combination of EC145 Plus Docetaxel Versus Docetaxel Alone in Participants With Folate-receptor Positive [FR(++)] Second Line NSCLC
Status: Enrolling
Updated: 2/8/2013
Willamette Valley Cancer Institute/Research Ctr
mi
from
Eugene, OR
Click here to add this to my saved trials
Phase 2 Study of EC145 Alone Versus EC145+Docetaxel Versus Docetaxel Alone in Participants With FR(++) 2nd Line Non Small Cell Lung Cancer
A Randomized, Open-label Phase 2 Study of EC145 Single-agent and the Combination of EC145 Plus Docetaxel Versus Docetaxel Alone in Participants With Folate-receptor Positive [FR(++)] Second Line NSCLC
Status: Enrolling
Updated:  2/8/2013
Oregon Health and Science University
mi
from
Portland, OR
Phase 2 Study of EC145 Alone Versus EC145+Docetaxel Versus Docetaxel Alone in Participants With FR(++) 2nd Line Non Small Cell Lung Cancer
A Randomized, Open-label Phase 2 Study of EC145 Single-agent and the Combination of EC145 Plus Docetaxel Versus Docetaxel Alone in Participants With Folate-receptor Positive [FR(++)] Second Line NSCLC
Status: Enrolling
Updated: 2/8/2013
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Phase 2 Study of EC145 Alone Versus EC145+Docetaxel Versus Docetaxel Alone in Participants With FR(++) 2nd Line Non Small Cell Lung Cancer
A Randomized, Open-label Phase 2 Study of EC145 Single-agent and the Combination of EC145 Plus Docetaxel Versus Docetaxel Alone in Participants With Folate-receptor Positive [FR(++)] Second Line NSCLC
Status: Enrolling
Updated:  2/8/2013
Penn State Hershey Cancer Institute
mi
from
Hershey, PA
Phase 2 Study of EC145 Alone Versus EC145+Docetaxel Versus Docetaxel Alone in Participants With FR(++) 2nd Line Non Small Cell Lung Cancer
A Randomized, Open-label Phase 2 Study of EC145 Single-agent and the Combination of EC145 Plus Docetaxel Versus Docetaxel Alone in Participants With Folate-receptor Positive [FR(++)] Second Line NSCLC
Status: Enrolling
Updated: 2/8/2013
Penn State Hershey Cancer Institute
mi
from
Hershey, PA
Click here to add this to my saved trials
Phase 2 Study of EC145 Alone Versus EC145+Docetaxel Versus Docetaxel Alone in Participants With FR(++) 2nd Line Non Small Cell Lung Cancer
A Randomized, Open-label Phase 2 Study of EC145 Single-agent and the Combination of EC145 Plus Docetaxel Versus Docetaxel Alone in Participants With Folate-receptor Positive [FR(++)] Second Line NSCLC
Status: Enrolling
Updated:  2/8/2013
Texas Oncology - Arlington South
mi
from
Arlington, TX
Phase 2 Study of EC145 Alone Versus EC145+Docetaxel Versus Docetaxel Alone in Participants With FR(++) 2nd Line Non Small Cell Lung Cancer
A Randomized, Open-label Phase 2 Study of EC145 Single-agent and the Combination of EC145 Plus Docetaxel Versus Docetaxel Alone in Participants With Folate-receptor Positive [FR(++)] Second Line NSCLC
Status: Enrolling
Updated: 2/8/2013
Texas Oncology - Arlington South
mi
from
Arlington, TX
Click here to add this to my saved trials
Phase 2 Study of EC145 Alone Versus EC145+Docetaxel Versus Docetaxel Alone in Participants With FR(++) 2nd Line Non Small Cell Lung Cancer
A Randomized, Open-label Phase 2 Study of EC145 Single-agent and the Combination of EC145 Plus Docetaxel Versus Docetaxel Alone in Participants With Folate-receptor Positive [FR(++)] Second Line NSCLC
Status: Enrolling
Updated:  2/8/2013
Texas Oncology-South Austin
mi
from
Austin, TX
Phase 2 Study of EC145 Alone Versus EC145+Docetaxel Versus Docetaxel Alone in Participants With FR(++) 2nd Line Non Small Cell Lung Cancer
A Randomized, Open-label Phase 2 Study of EC145 Single-agent and the Combination of EC145 Plus Docetaxel Versus Docetaxel Alone in Participants With Folate-receptor Positive [FR(++)] Second Line NSCLC
Status: Enrolling
Updated: 2/8/2013
Texas Oncology-South Austin
mi
from
Austin, TX
Click here to add this to my saved trials
Phase 2 Study of EC145 Alone Versus EC145+Docetaxel Versus Docetaxel Alone in Participants With FR(++) 2nd Line Non Small Cell Lung Cancer
A Randomized, Open-label Phase 2 Study of EC145 Single-agent and the Combination of EC145 Plus Docetaxel Versus Docetaxel Alone in Participants With Folate-receptor Positive [FR(++)] Second Line NSCLC
Status: Enrolling
Updated:  2/8/2013
Texas Oncology-Beaumont, Mamie McFaddin Ward Cancer Center
mi
from
Beaumont, TX
Phase 2 Study of EC145 Alone Versus EC145+Docetaxel Versus Docetaxel Alone in Participants With FR(++) 2nd Line Non Small Cell Lung Cancer
A Randomized, Open-label Phase 2 Study of EC145 Single-agent and the Combination of EC145 Plus Docetaxel Versus Docetaxel Alone in Participants With Folate-receptor Positive [FR(++)] Second Line NSCLC
Status: Enrolling
Updated: 2/8/2013
Texas Oncology-Beaumont, Mamie McFaddin Ward Cancer Center
mi
from
Beaumont, TX
Click here to add this to my saved trials
Phase 2 Study of EC145 Alone Versus EC145+Docetaxel Versus Docetaxel Alone in Participants With FR(++) 2nd Line Non Small Cell Lung Cancer
A Randomized, Open-label Phase 2 Study of EC145 Single-agent and the Combination of EC145 Plus Docetaxel Versus Docetaxel Alone in Participants With Folate-receptor Positive [FR(++)] Second Line NSCLC
Status: Enrolling
Updated:  2/8/2013
Texas Oncology, P.A. - Bedford
mi
from
Bedford, TX
Phase 2 Study of EC145 Alone Versus EC145+Docetaxel Versus Docetaxel Alone in Participants With FR(++) 2nd Line Non Small Cell Lung Cancer
A Randomized, Open-label Phase 2 Study of EC145 Single-agent and the Combination of EC145 Plus Docetaxel Versus Docetaxel Alone in Participants With Folate-receptor Positive [FR(++)] Second Line NSCLC
Status: Enrolling
Updated: 2/8/2013
Texas Oncology, P.A. - Bedford
mi
from
Bedford, TX
Click here to add this to my saved trials
Phase 2 Study of EC145 Alone Versus EC145+Docetaxel Versus Docetaxel Alone in Participants With FR(++) 2nd Line Non Small Cell Lung Cancer
A Randomized, Open-label Phase 2 Study of EC145 Single-agent and the Combination of EC145 Plus Docetaxel Versus Docetaxel Alone in Participants With Folate-receptor Positive [FR(++)] Second Line NSCLC
Status: Enrolling
Updated:  2/8/2013
U.T. Southwestern Medical Center
mi
from
Dallas, TX
Phase 2 Study of EC145 Alone Versus EC145+Docetaxel Versus Docetaxel Alone in Participants With FR(++) 2nd Line Non Small Cell Lung Cancer
A Randomized, Open-label Phase 2 Study of EC145 Single-agent and the Combination of EC145 Plus Docetaxel Versus Docetaxel Alone in Participants With Folate-receptor Positive [FR(++)] Second Line NSCLC
Status: Enrolling
Updated: 2/8/2013
U.T. Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Phase 2 Study of EC145 Alone Versus EC145+Docetaxel Versus Docetaxel Alone in Participants With FR(++) 2nd Line Non Small Cell Lung Cancer
A Randomized, Open-label Phase 2 Study of EC145 Single-agent and the Combination of EC145 Plus Docetaxel Versus Docetaxel Alone in Participants With Folate-receptor Positive [FR(++)] Second Line NSCLC
Status: Enrolling
Updated:  2/8/2013
Texas Oncology-Plano East
mi
from
Plano, TX
Phase 2 Study of EC145 Alone Versus EC145+Docetaxel Versus Docetaxel Alone in Participants With FR(++) 2nd Line Non Small Cell Lung Cancer
A Randomized, Open-label Phase 2 Study of EC145 Single-agent and the Combination of EC145 Plus Docetaxel Versus Docetaxel Alone in Participants With Folate-receptor Positive [FR(++)] Second Line NSCLC
Status: Enrolling
Updated: 2/8/2013
Texas Oncology-Plano East
mi
from
Plano, TX
Click here to add this to my saved trials
Phase 2 Study of EC145 Alone Versus EC145+Docetaxel Versus Docetaxel Alone in Participants With FR(++) 2nd Line Non Small Cell Lung Cancer
A Randomized, Open-label Phase 2 Study of EC145 Single-agent and the Combination of EC145 Plus Docetaxel Versus Docetaxel Alone in Participants With Folate-receptor Positive [FR(++)] Second Line NSCLC
Status: Enrolling
Updated:  2/8/2013
Texas Oncology-Tyler
mi
from
Tyler, TX
Phase 2 Study of EC145 Alone Versus EC145+Docetaxel Versus Docetaxel Alone in Participants With FR(++) 2nd Line Non Small Cell Lung Cancer
A Randomized, Open-label Phase 2 Study of EC145 Single-agent and the Combination of EC145 Plus Docetaxel Versus Docetaxel Alone in Participants With Folate-receptor Positive [FR(++)] Second Line NSCLC
Status: Enrolling
Updated: 2/8/2013
Texas Oncology-Tyler
mi
from
Tyler, TX
Click here to add this to my saved trials
Phase 2 Study of EC145 Alone Versus EC145+Docetaxel Versus Docetaxel Alone in Participants With FR(++) 2nd Line Non Small Cell Lung Cancer
A Randomized, Open-label Phase 2 Study of EC145 Single-agent and the Combination of EC145 Plus Docetaxel Versus Docetaxel Alone in Participants With Folate-receptor Positive [FR(++)] Second Line NSCLC
Status: Enrolling
Updated:  2/8/2013
Kadlec Hematology & Oncology
mi
from
Kennewick, WA
Phase 2 Study of EC145 Alone Versus EC145+Docetaxel Versus Docetaxel Alone in Participants With FR(++) 2nd Line Non Small Cell Lung Cancer
A Randomized, Open-label Phase 2 Study of EC145 Single-agent and the Combination of EC145 Plus Docetaxel Versus Docetaxel Alone in Participants With Folate-receptor Positive [FR(++)] Second Line NSCLC
Status: Enrolling
Updated: 2/8/2013
Kadlec Hematology & Oncology
mi
from
Kennewick, WA
Click here to add this to my saved trials
Feasibility of Pre-Surgical Intervention Studies for Evaluating Targeted Therapies for Breast Cancer
Feasibility of Pre-Surgical Intervention Studies for Evaluating Targeted Therapies for Breast Cancer
Status: Enrolling
Updated:  2/11/2013
Columbia University Medical Center
mi
from
New York, NY
Feasibility of Pre-Surgical Intervention Studies for Evaluating Targeted Therapies for Breast Cancer
Feasibility of Pre-Surgical Intervention Studies for Evaluating Targeted Therapies for Breast Cancer
Status: Enrolling
Updated: 2/11/2013
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Use of an In Vivo Optical Probe to Discriminate Benign From Malignant Thyroid Nodules
Optical Probe In Thyroid Cancer
Status: Enrolling
Updated:  2/13/2013
Boston Med Ctr
mi
from
Boston, MA
Use of an In Vivo Optical Probe to Discriminate Benign From Malignant Thyroid Nodules
Optical Probe In Thyroid Cancer
Status: Enrolling
Updated: 2/13/2013
Boston Med Ctr
mi
from
Boston, MA
Click here to add this to my saved trials
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated:  2/13/2013
Foundation for Cancer Research and Education
mi
from
Phoenix, AZ
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated: 2/13/2013
Foundation for Cancer Research and Education
mi
from
Phoenix, AZ
Click here to add this to my saved trials
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated:  2/13/2013
Urological Surgeons of Northern California
mi
from
Campbell, CA
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated: 2/13/2013
Urological Surgeons of Northern California
mi
from
Campbell, CA
Click here to add this to my saved trials
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated:  2/13/2013
Radiological Associates of Sacramento
mi
from
Sacramento, CA
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated: 2/13/2013
Radiological Associates of Sacramento
mi
from
Sacramento, CA
Click here to add this to my saved trials
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated:  2/13/2013
The Urology Center of Colorado
mi
from
Denver, CO
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated: 2/13/2013
The Urology Center of Colorado
mi
from
Denver, CO
Click here to add this to my saved trials
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated:  2/13/2013
Lakewood Ranch Oncology Center/21st Century Oncology
mi
from
Bradenton, FL
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated: 2/13/2013
Lakewood Ranch Oncology Center/21st Century Oncology
mi
from
Bradenton, FL
Click here to add this to my saved trials
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated:  2/13/2013
21st Century Oncology
mi
from
Plantation, FL
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated: 2/13/2013
21st Century Oncology
mi
from
Plantation, FL
Click here to add this to my saved trials
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated:  2/13/2013
Emory University
mi
from
Atlanta, GA
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated: 2/13/2013
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated:  2/13/2013
Johns Hopkins University Department of Radiation Oncology and Molecular Radiation Sciences
mi
from
Baltimore, MD
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated: 2/13/2013
Johns Hopkins University Department of Radiation Oncology and Molecular Radiation Sciences
mi
from
Baltimore, MD
Click here to add this to my saved trials
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated:  2/13/2013
Chesapeake Urology Associates, Chesapeake Urology Research Associates (The Prostate Center)
mi
from
Owings Mills, MD
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated: 2/13/2013
Chesapeake Urology Associates, Chesapeake Urology Research Associates (The Prostate Center)
mi
from
Owings Mills, MD
Click here to add this to my saved trials
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated:  2/13/2013
Northern Nevada Radiation Oncology
mi
from
Reno, NV
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated: 2/13/2013
Northern Nevada Radiation Oncology
mi
from
Reno, NV
Click here to add this to my saved trials
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated:  2/13/2013
CentraState Medical Center
mi
from
Freehold, NJ
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated: 2/13/2013
CentraState Medical Center
mi
from
Freehold, NJ
Click here to add this to my saved trials
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated:  2/13/2013
Western New York Urology Associates, LLC and D/B/A Cancer Care of WNY
mi
from
Erie, Niagara, and Chautauqua County, NY
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated: 2/13/2013
Western New York Urology Associates, LLC and D/B/A Cancer Care of WNY
mi
from
Erie, Niagara, and Chautauqua County, NY
Click here to add this to my saved trials
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated:  2/13/2013
Advanced Radiation Centers of New York
mi
from
Lake Success, NY
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated: 2/13/2013
Advanced Radiation Centers of New York
mi
from
Lake Success, NY
Click here to add this to my saved trials
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated:  2/13/2013
University of Rochester
mi
from
Rochester, NY
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated: 2/13/2013
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated:  2/13/2013
Upstate Medical University
mi
from
Syracuse, NY
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated: 2/13/2013
Upstate Medical University
mi
from
Syracuse, NY
Click here to add this to my saved trials
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated:  2/13/2013
Associated Medical Professionals of NY
mi
from
Syracuse, NY
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated: 2/13/2013
Associated Medical Professionals of NY
mi
from
Syracuse, NY
Click here to add this to my saved trials
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated:  2/13/2013
University Hospitals of Cleveland
mi
from
Cleveland, OH
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated: 2/13/2013
University Hospitals of Cleveland
mi
from
Cleveland, OH
Click here to add this to my saved trials
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated:  2/13/2013
Oregon Urology Institute
mi
from
Springfield, OR
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated: 2/13/2013
Oregon Urology Institute
mi
from
Springfield, OR
Click here to add this to my saved trials
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated:  2/13/2013
21st Century Oncology
mi
from
Myrtle Beach, SC
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated: 2/13/2013
21st Century Oncology
mi
from
Myrtle Beach, SC
Click here to add this to my saved trials
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated:  2/13/2013
Peninsula Cancer Center
mi
from
Poulsbo, WA
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated: 2/13/2013
Peninsula Cancer Center
mi
from
Poulsbo, WA
Click here to add this to my saved trials
Breast Cancer, Aromatase Inhibitor Therapy, and Sexual Functioning: The Effects of Vaginal Testosterone Therapy
Breast Cancer, Aromatase Inhibitor Therapy, and Sexual Functioning: A Pilot Study on the Effects of Vaginal Testosterone Therapy
Status: Enrolling
Updated:  2/13/2013
Nebraska Cancer Specialists/Midwest Cancer Center - Legacy
mi
from
Omaha, NE
Breast Cancer, Aromatase Inhibitor Therapy, and Sexual Functioning: The Effects of Vaginal Testosterone Therapy
Breast Cancer, Aromatase Inhibitor Therapy, and Sexual Functioning: A Pilot Study on the Effects of Vaginal Testosterone Therapy
Status: Enrolling
Updated: 2/13/2013
Nebraska Cancer Specialists/Midwest Cancer Center - Legacy
mi
from
Omaha, NE
Click here to add this to my saved trials
Adjuvant Valproate for High Grade Sarcomas
A Pilot Study of Adjuvant Valproate for Patients With High Grade Sarcomas
Status: Enrolling
Updated:  2/14/2013
Columbia University Medical Center
mi
from
New York, NY
Adjuvant Valproate for High Grade Sarcomas
A Pilot Study of Adjuvant Valproate for Patients With High Grade Sarcomas
Status: Enrolling
Updated: 2/14/2013
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Phase I Trial of Intratumoral Administration of HF10, A Replication Competent Herpes Simplex Virus Type 1, in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Status: Enrolling
Updated:  2/18/2013
Montefiore Medical Center
mi
from
Bronx, NY
Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Phase I Trial of Intratumoral Administration of HF10, A Replication Competent Herpes Simplex Virus Type 1, in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Status: Enrolling
Updated: 2/18/2013
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Phase I Trial of Intratumoral Administration of HF10, A Replication Competent Herpes Simplex Virus Type 1, in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Status: Enrolling
Updated:  2/18/2013
Oregon Health and Science University
mi
from
Portland, OR
Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Phase I Trial of Intratumoral Administration of HF10, A Replication Competent Herpes Simplex Virus Type 1, in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Status: Enrolling
Updated: 2/18/2013
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Phase I Trial of Intratumoral Administration of HF10, A Replication Competent Herpes Simplex Virus Type 1, in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Status: Enrolling
Updated:  2/18/2013
University of Pittsburgh
mi
from
Pittsburgh, PA
Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Phase I Trial of Intratumoral Administration of HF10, A Replication Competent Herpes Simplex Virus Type 1, in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Status: Enrolling
Updated: 2/18/2013
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Phase I Trial of Intratumoral Administration of HF10, A Replication Competent Herpes Simplex Virus Type 1, in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Status: Enrolling
Updated:  2/18/2013
Mary Crowley Cancer Research Center
mi
from
Dallas, TX
Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Phase I Trial of Intratumoral Administration of HF10, A Replication Competent Herpes Simplex Virus Type 1, in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Status: Enrolling
Updated: 2/18/2013
Mary Crowley Cancer Research Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Phase I Trial of Intratumoral Administration of HF10, A Replication Competent Herpes Simplex Virus Type 1, in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Status: Enrolling
Updated:  2/18/2013
Huntsman Cancer Institute
mi
from
Salt Lake, UT
Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Phase I Trial of Intratumoral Administration of HF10, A Replication Competent Herpes Simplex Virus Type 1, in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Status: Enrolling
Updated: 2/18/2013
Huntsman Cancer Institute
mi
from
Salt Lake, UT
Click here to add this to my saved trials
Efficacy and Safety of a Sunscreen Against Porfimer Sodium-induced Phototoxicity to Visible Light
Prospective, Randomized, Controlled, Partially Blinded, Skin Photobiological Clinical Study of the Efficacy and Safety of a Sunscreen Product as Skin Protector Against Porfimer Sodium-induced Phototoxicity to Visible Light
Status: Enrolling
Updated:  2/18/2013
St. Mary's Hospital - Mayo Clinic
mi
from
Rochester, MN
Efficacy and Safety of a Sunscreen Against Porfimer Sodium-induced Phototoxicity to Visible Light
Prospective, Randomized, Controlled, Partially Blinded, Skin Photobiological Clinical Study of the Efficacy and Safety of a Sunscreen Product as Skin Protector Against Porfimer Sodium-induced Phototoxicity to Visible Light
Status: Enrolling
Updated: 2/18/2013
St. Mary's Hospital - Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Efficacy and Safety of a Sunscreen Against Porfimer Sodium-induced Phototoxicity to Visible Light
Prospective, Randomized, Controlled, Partially Blinded, Skin Photobiological Clinical Study of the Efficacy and Safety of a Sunscreen Product as Skin Protector Against Porfimer Sodium-induced Phototoxicity to Visible Light
Status: Enrolling
Updated:  2/18/2013
Ohio State University
mi
from
Columbus, OH
Efficacy and Safety of a Sunscreen Against Porfimer Sodium-induced Phototoxicity to Visible Light
Prospective, Randomized, Controlled, Partially Blinded, Skin Photobiological Clinical Study of the Efficacy and Safety of a Sunscreen Product as Skin Protector Against Porfimer Sodium-induced Phototoxicity to Visible Light
Status: Enrolling
Updated: 2/18/2013
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line Therapy
A Phase 2, Open Label, Multicenter, Randomized Trial Comparing Tivozanib in Combination With mFOLFOX6 to Bevacizumab in Combination With mFOLFOX6, In Stage IV Metastatic Colorectal Cancer (mCRC) Subjects
Status: Enrolling
Updated:  2/19/2013
Banner MD Anderson Cancer Center
mi
from
Gilbert, AZ
A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line Therapy
A Phase 2, Open Label, Multicenter, Randomized Trial Comparing Tivozanib in Combination With mFOLFOX6 to Bevacizumab in Combination With mFOLFOX6, In Stage IV Metastatic Colorectal Cancer (mCRC) Subjects
Status: Enrolling
Updated: 2/19/2013
Banner MD Anderson Cancer Center
mi
from
Gilbert, AZ
Click here to add this to my saved trials
A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line Therapy
A Phase 2, Open Label, Multicenter, Randomized Trial Comparing Tivozanib in Combination With mFOLFOX6 to Bevacizumab in Combination With mFOLFOX6, In Stage IV Metastatic Colorectal Cancer (mCRC) Subjects
Status: Enrolling
Updated:  2/19/2013
Genesis Cancer Center
mi
from
Hot Springs, AZ
A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line Therapy
A Phase 2, Open Label, Multicenter, Randomized Trial Comparing Tivozanib in Combination With mFOLFOX6 to Bevacizumab in Combination With mFOLFOX6, In Stage IV Metastatic Colorectal Cancer (mCRC) Subjects
Status: Enrolling
Updated: 2/19/2013
Genesis Cancer Center
mi
from
Hot Springs, AZ
Click here to add this to my saved trials
A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line Therapy
A Phase 2, Open Label, Multicenter, Randomized Trial Comparing Tivozanib in Combination With mFOLFOX6 to Bevacizumab in Combination With mFOLFOX6, In Stage IV Metastatic Colorectal Cancer (mCRC) Subjects
Status: Enrolling
Updated:  2/19/2013
Arizona Clinical Research Center
mi
from
Tucson, AZ
A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line Therapy
A Phase 2, Open Label, Multicenter, Randomized Trial Comparing Tivozanib in Combination With mFOLFOX6 to Bevacizumab in Combination With mFOLFOX6, In Stage IV Metastatic Colorectal Cancer (mCRC) Subjects
Status: Enrolling
Updated: 2/19/2013
Arizona Clinical Research Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line Therapy
A Phase 2, Open Label, Multicenter, Randomized Trial Comparing Tivozanib in Combination With mFOLFOX6 to Bevacizumab in Combination With mFOLFOX6, In Stage IV Metastatic Colorectal Cancer (mCRC) Subjects
Status: Enrolling
Updated:  2/19/2013
University of California at San Diego
mi
from
San Diego, CA
A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line Therapy
A Phase 2, Open Label, Multicenter, Randomized Trial Comparing Tivozanib in Combination With mFOLFOX6 to Bevacizumab in Combination With mFOLFOX6, In Stage IV Metastatic Colorectal Cancer (mCRC) Subjects
Status: Enrolling
Updated: 2/19/2013
University of California at San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line Therapy
A Phase 2, Open Label, Multicenter, Randomized Trial Comparing Tivozanib in Combination With mFOLFOX6 to Bevacizumab in Combination With mFOLFOX6, In Stage IV Metastatic Colorectal Cancer (mCRC) Subjects
Status: Enrolling
Updated:  2/19/2013
UC Irvine Medical Center, Division of Hematology/Oncology
mi
from
Orange, CA
A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line Therapy
A Phase 2, Open Label, Multicenter, Randomized Trial Comparing Tivozanib in Combination With mFOLFOX6 to Bevacizumab in Combination With mFOLFOX6, In Stage IV Metastatic Colorectal Cancer (mCRC) Subjects
Status: Enrolling
Updated: 2/19/2013
UC Irvine Medical Center, Division of Hematology/Oncology
mi
from
Orange, CA
Click here to add this to my saved trials
A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line Therapy
A Phase 2, Open Label, Multicenter, Randomized Trial Comparing Tivozanib in Combination With mFOLFOX6 to Bevacizumab in Combination With mFOLFOX6, In Stage IV Metastatic Colorectal Cancer (mCRC) Subjects
Status: Enrolling
Updated:  2/19/2013
Desert Hematology Oncology Medical Group
mi
from
Rancho Mirage, CA
A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line Therapy
A Phase 2, Open Label, Multicenter, Randomized Trial Comparing Tivozanib in Combination With mFOLFOX6 to Bevacizumab in Combination With mFOLFOX6, In Stage IV Metastatic Colorectal Cancer (mCRC) Subjects
Status: Enrolling
Updated: 2/19/2013
Desert Hematology Oncology Medical Group
mi
from
Rancho Mirage, CA
Click here to add this to my saved trials
A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line Therapy
A Phase 2, Open Label, Multicenter, Randomized Trial Comparing Tivozanib in Combination With mFOLFOX6 to Bevacizumab in Combination With mFOLFOX6, In Stage IV Metastatic Colorectal Cancer (mCRC) Subjects
Status: Enrolling
Updated:  2/19/2013
Mountain Blue Cancer Care Center
mi
from
Wheat Ridge, CO
A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line Therapy
A Phase 2, Open Label, Multicenter, Randomized Trial Comparing Tivozanib in Combination With mFOLFOX6 to Bevacizumab in Combination With mFOLFOX6, In Stage IV Metastatic Colorectal Cancer (mCRC) Subjects
Status: Enrolling
Updated: 2/19/2013
Mountain Blue Cancer Care Center
mi
from
Wheat Ridge, CO
Click here to add this to my saved trials